Jiangsu GDK Biotechnology Co Ltd (688670) — Cash Flow-to-Debt Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow-to-Debt Ratio of -0.17x as of September 2025, meaning its operating cash flow of CN¥-44.96 Million could theoretically repay 0% of its total liabilities (CN¥257.05 Million) in one year. See Jiangsu GDK Biotechnology Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu GDK Biotechnology Co Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Jiangsu GDK Biotechnology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 688670 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Jiangsu GDK Biotechnology Co Ltd (2017–2025)
Year-by-year debt coverage analysis for Jiangsu GDK Biotechnology Co Ltd. Check 688670 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | CN¥-166.45 Million | CN¥319.50 Million | ▼ -1.2% |
| 2024 | -0.51x | CN¥-131.39 Million | CN¥255.33 Million | ▼ -265.7% |
| 2023 | 0.31x | CN¥80.90 Million | CN¥260.52 Million | ▲ +195.4% |
| 2022 | 0.11x | CN¥38.60 Million | CN¥367.11 Million | ▼ -70.3% |
| 2021 | 0.35x | CN¥103.93 Million | CN¥293.12 Million | ▲ +73.5% |
| 2020 | 0.20x | CN¥109.46 Million | CN¥535.47 Million | ▲ +291.2% |
| 2019 | -0.11x | CN¥-54.05 Million | CN¥505.68 Million | ▼ -20.7% |
| 2018 | -0.09x | CN¥-35.48 Million | CN¥400.73 Million | ▲ +4.3% |
| 2017 | -0.09x | CN¥-33.24 Million | CN¥359.39 Million | — |